| 前收盘价格 | 44.98 |
| 收盘价格 | 44.72 |
| 成交量 | 259,977 |
| 平均成交量 (3个月) | 575,108 |
| 市值 | 2,061,097,600 |
| 价格/销量 (P/S) | 1.86 |
| 股市价格/股市净资产 (P/B) | 1.62 |
| 52周波幅 | |
| 利润日期 | 6 Feb 2025 - 10 Feb 2025 |
| 营业毛利率 | -1.66% |
| 营业利益率 (TTM) | 2.54% |
| 稀释每股收益 (EPS TTM) | -0.390 |
| 季度收入增长率 (YOY) | -5.40% |
| 季度盈利增长率 (YOY) | 55.40% |
| 总债务/股东权益 (D/E MRQ) | 49.88% |
| 流动比率 (MRQ) | 1.05 |
| 营业现金流 (OCF TTM) | 169.82 M |
| 杠杆自由现金流 (LFCF TTM) | 109.36 M |
| 资产报酬率 (ROA TTM) | -0.87% |
| 股东权益报酬率 (ROE TTM) | -1.46% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | Omnicell, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-0.3
| 分析师共识 | 1.5 |
| 内部交易活动 | -1.5 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.30 |
|
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 1.63% |
| 机构持股比例 | 101.25% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 64.00 (Craig-Hallum, 43.82%) | 购买 |
| 中 | 52.50 (17.98%) | |
| 低 | 41.00 (Wells Fargo, -7.87%) | 保留 |
| 平均值 | 52.00 (16.85%) | |
| 总计 | 2 购买, 4 保留 | |
| 平均价格@调整类型 | 45.95 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 21 Nov 2024 | 44.00 (-1.12%) | 保留 | 44.11 |
| B of A Securities | 31 Oct 2024 | 57.00 (28.09%) | 保留 | 48.64 |
| Barclays | 31 Oct 2024 | 58.00 (30.34%) | 保留 | 48.64 |
| Craig-Hallum | 31 Oct 2024 | 64.00 (43.82%) | 购买 | 48.64 |
| Wells Fargo | 14 Oct 2024 | 41.00 (-7.87%) | 保留 | 42.73 |
| Benchmark | 09 Oct 2024 | 48.00 (7.87%) | 购买 | 42.95 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| LIPPS RANDALL A | - | 46.01 | -4,202 | -193,334 |
| MANLEY COREY J | - | 46.01 | -222 | -10,214 |
| 累积净数量 | -4,424 | |||
| 累积净值 ($) | -203,548 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 46.01 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| LIPPS RANDALL A | 职员 | 15 Dec 2024 | 处理 (-) | 4,202 | 46.01 | 193,334 |
| MANLEY COREY J | 职员 | 15 Dec 2024 | 处理 (-) | 222 | 46.01 | 10,214 |
| 日期 | 类型 | 细节 |
|---|---|---|
| 09 Dec 2024 | 公告 | Omnicell Announces OmniSphere |
| 22 Nov 2024 | 公告 | Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference |
| 20 Nov 2024 | 公告 | Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering |
| 18 Nov 2024 | 公告 | Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes |
| 30 Oct 2024 | 公告 | Omnicell Announces Third Quarter 2024 Results |
| 07 Oct 2024 | 公告 | Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合